Global Enteric Disease Testing Market Size to Exceed USD 4.93 Billion by 2033: Industry Report

Global Enteric Disease Testing Market Size To Exceed USD 4.93 Billion by 2033                

According to a research report published by Spherical Insights & Consulting, the Global Enteric Disease Testing Market Size is Expected to Grow from USD 3.90 Billion in 2023 to USD 4.93 Billion by 2033, at a CAGR of 2.37% during the forecast period 2023-2033.          

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Enteric Disease Testing Market Size, Share, and COVID-19 Impact Analysis, By Disease Type (Bacterial Enteric Disease, Viral Enteric Disease [Rotavirus and Norovirus], and Parasitic Enteric Disease), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

The enteric disease testing market is a business that deals with diagnosing, detecting, and monitoring infections of the gastrointestinal tract. Such infections, which are mostly caused by viruses, bacteria, or parasites, cause diseases such as diarrhea, food poisoning, and gastroenteritis. Furthermore, the global enteric disease testing market is driven by rising cases of foodborne and waterborne infections, increasing awareness of early diagnosis, and advancements in diagnostic technologies. Growing healthcare investments, improved sanitation initiatives, and government regulations for food and water safety further boost market growth. Additionally, the demand for rapid and accurate testing methods enhances market expansion during the forecast period. However, the high costs, limited access in low-income regions, lack of awareness, regulatory hurdles, inconsistent test accuracy, and inadequate healthcare infrastructure in developing nations are key restraints for the growth of the market.

The bacterial enteric disease segment is estimated for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.           

On the basis of the disease type, the global enteric disease testing market is segmented into bacterial enteric disease, viral enteric disease, and parasitic enteric disease. The viral enteric disease is divided into rotavirus and norovirus. Among these, the bacterial enteric disease segment is estimated for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to the high prevalence rates, increasing outbreaks, and rising demand for rapid diagnostics. Advancements in testing technologies, growing healthcare investments, and heightened awareness drive its anticipated significant CAGR growth during the forecast period, ensuring early detection and effective disease management.

North America is projected to hold the largest share of the global enteric disease testing market over the forecast period.

North America is projected to hold the largest share of the global enteric disease testing market over the forecast period. North America's dominance in the global enteric disease testing market is driven by advanced healthcare infrastructure, high awareness, and increased adoption of advanced diagnostic technologies. Rising foodborne disease cases, stringent government regulations, and significant investments in research further contribute to market growth. Additionally, the strong presence of key industry players enhances regional market expansion.

Asia Pacific is expected to grow at the fastest CAGR growth of the global enteric disease testing market during the forecast period. The regional growth is attributed to the increasing prevalence of enteric diseases, improving healthcare infrastructure, and rising awareness. Rapid urbanization, population growth, and government initiatives for better diagnostics drive demand. Additionally, expanding access to advanced testing technologies and increasing healthcare investments further propel market expansion in the region.

Company profiling

Major vendors in the global enteric disease testing market are Abbott, BD, Biomerica, BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Cepheid, Coris BioConcept, DiaSorin S.p.A., Meridian Bioscience, Quest Diagnostics Incorporated, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global enteric disease testing market based on the below-mentioned segments: 

Global Enteric Disease Testing Market, By Disease Type

• Bacterial Enteric Disease
• Viral Enteric Disease
  • Rotavirus
  • Norovirus
• Parasitic Enteric Disease

 Global Enteric Disease Testing Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa